XSNX Announces Start of CIGSolar(R) CIS Processing Company

New Post Public Reply Private Reply Replies (0) Message Board

Mar 1, 2013 at 9:06 AM

XSNX >>Announces Start of CIGSolar(R) CIS Processing
Company Begins Final Phase in Preparing System for Customer Demonstrations

Press Release: XsunX, Inc. – Wed, Jan 16, 2013 5:53 AM EST
Email
RecommendTweet1
Print
RELATED QUOTES
Symbol Price Change
XSNX 0.019

IRVINE, CA--(Marketwire - Jan 16, 2013) - XsunX, Inc. ( OTCQB : XSNX ), the developer of CIGSolar®, a patent-pending solar cell manufacturing process offering a capital-efficient, low-cost alternative to the use of silicon solar cells, today announced it had begun processing CIS films with its recently completed CIGSolar® TFPV solar cell evaporation system. The Company has been testing and calibrating the deposition source technology in its new evaporation system so that it could transition to processing CIGS films.
"Recently we initiated the last phase necessary for preparing our CIGSolar® TFPV solar cell evaporation system for customer demonstrations with the initiation of CIS (Copper Indium and Selenium) film processing," said Tom Djokovich, CEO of XsunX. "This represents a major step forward and allows us to then transition to CIGS (Copper Indium Gallium and Selenium) films and the completion of the system's readiness for demonstrations," added Mr. Djokovich.
The Company's technology utilizes multi-small area thermal co-evaporation technology to deposit the CIGS solar absorber onto thin stainless steel substrates. The stainless steel substrate can be sized to match silicon solar cells for use as a low cost alternative to silicon solar cells. In addition, the flexible aspect of the stainless steel substrate could also be used in applications where flexibility is required such as building-integrated PV (BIPV) applications.
According to analysts, markets for BIPV installations are predicted to grow by $5 billion U.S. over the next two years. The flexibility of CIGSolar® cells could offer BIPV manufacturers the potential to use cells manufactured using the CIGSolar® process in their products, opening up new market opportunities for XsunX. With the closure of some thin film manufacturers and scaling back of production with others, the Company has begun to receive inquiries related to BIPV applications for CIGSolar® cells.
"There was a lot of buzz over CIGS PV that began to develop in 2009 and grew into 2010," stated Mr. Djokovich. "But with the rapid decline in silicon pricing, many companies focused on producing products to compete with silicon module assemblers have either closed or sold out. XsunX took a different approach with CIGSolar®. Rather than develop a product that attempts to compete with assemblers of silicon solar modules, which is a business path that has seen the demise of numerous thin film companies such as Solyndra, XsunX's CIGSolar® is designed to offer pre-existing silicon module assemblers a lower cost replacement to silicon. Our business objective is to leverage the many GW of existing assembly capacity in the market -- not compete with it. Now it appears that the flexibility of our stainless steel substrates may also offer an alternative cell for BIPV assemblers as well. At this time, we are pleased to find interest in our CIGSolar® technology coming from multiple areas in the solar market," concluded Mr. Djokovich.
About XsunX
XsunX, Inc. is developing a new manufacturing process to produce low cost, high efficiency thin-film Copper Indium Gallium (di) Selenide (CIGS) thin film solar cells. The patent pending deposition system coupled with proprietary processing technology, which XsunX calls CIGSolar®, focuses on the mass production of individual thin-film CIGS solar cells that match silicon solar cell dimensions and can be offered as a non-toxic, high-efficiency and lowest-cost alternative to the use of silicon solar cells. The company is offering licenses for the use of the CIGSolar® process technology, and plans to generate revenue through licensing fees and manufacturing royalties for the use of the CIGSolar® technology.
For more information please call XsunX at 888-797-4527, or visit the company's website at www.xsunx.com.
Safe Harbor Statement
Matters discussed in this press release contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the Company's actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as "may," "will," "should," "believes," "expect," "intend," "anticipate," "plan," "estimate" to be uncertain and forward-looking. The forward-looking statements contained herein are also subject to risks and uncertainties that are described in our most recent annual report on Form 10-K under the heading "Risk Factors" and our subsequent filings with the Securities and Exchange Commission. We do not undertake any obligation to update publicly any forward-looking statements whether as a result of the receipt of new information, future events, or otherwise.
Contact:
XsunX
888-797-4527
www.xsunx.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Portillo's Faces Class Action: Investor Losses at Stake

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Investors Gear Up for Lennar Class Action Lawsuit

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Viking Ventures: Impacts of VK2735 on Obesity Examined

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...